News

ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.

Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.

The company has the elements that make a fantastic long-term investment.

While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Piper Sandler Companies stock has delivered a strong 5 year return, yet with the recent pullback and a mixed valuation score, the current share price around US$71.09 looks less like a straightforward bargain and more like a test of how much investors are willing to pay for its track record. Over the past 5 years the stock has returned 165.8%, which sets a high bar for future returns to justify the current valuation. Positive sentiment around Piper Sandler's research and advisory work, such...

Intuitive Surgical (NasdaqGS:ISRG) reported strong quarterly results, supported by solid procedure volumes and rapid adoption of its new da Vinci 5 system. Management issued softer guidance for future procedure growth, citing competitive pressures and increased regulatory scrutiny. The company was recently added to the Russell 1000 Dynamic Index and removed from the Russell Top 50 Index, altering its index exposure. Intuitive Surgical focuses on robotic assisted surgery, with its da Vinci...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.

Intuitive Surgical has faced margin pressure before and bounced back.

Intuitive Surgical is approaching a pivotal earnings update as strong forecasts square off against a stock that has lost its footing.

In this month’s Mailbag, Fools write in about market caps, parenting, AI, adding to winning investments, and what can happen when decades of patient investing quietly compound into opportunities to help others.

Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Brown Advisory, an investment management company, released its “Brown Large-Cap Growth Strategy” for the first-quarter 2026 investor letter. A copy of the letter is available to download here. The Brown Advisory Large-Cap Growth Strategy experienced a decline in the first quarter of 2026, modestly trailing the Russell 1000 Growth Index. Despite negative absolute returns amidst volatility, […]

Intuitive Surgical, Inc. (NASDAQ:ISRG) has declined more than 29% over the past 6 months and is now trading close to its 52-week lows. The downward pressure stems from regulatory scrutiny regarding instrument reuse and concerns over Chinese competition. ​However, the Street expects the stock to rebound, with analysts’ 12-month average price target suggesting more than […]

Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for investors weighing portfolio strategy.

Stryker (NYSE:SYK) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results. Stryker absorbed a March 11 cyberattack and heavy restructuring charges while defending its joint replacement franchise. Intuitive posted another crisp beat on the back of da Vinci 5 adoption. Two medtech giants, two very different quarters. A Cyber ... Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation

The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance and delivering strong returns.

The company dominates the robotic surgery market.

Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.

Intuitive Surgical has been a huge winner over the long term, but there's a potential opening for new investors right now.

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $404.27, denoting a +1.14% move from the preceding trading day.

Intuitive Surgical, Inc. (NASDAQ:ISRG) ranks among the best set-it-and-forget-it stocks to buy right now. On June 2, Piper Sandler restated its Overweight rating and $580 target on Intuitive Surgical, Inc. (NASDAQ:ISRG). The firm’s recent field check with the head of robotics at a prominent U.S. healthcare institution confirmed the firm’s positive opinion of the company. […]

Goldman Sachs and several industry analysts have publicly backed Intuitive Surgical's core business, following concerns about new rules on instrument reuse. The commentary argues that regulatory driven changes to reuse policies are unlikely to cause major disruption to Intuitive Surgical's revenue model. The defense comes after a period of share price pressure and renewed debate about the long term outlook for NasdaqGS:ISRG. Intuitive Surgical enters this debate with its stock under...

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.

These companies' innovative qualities could help them get ahead of their peers in capitalizing on AI.

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the 10 best robotics and automation stocks to invest in. On June 17, Good Samaritan Hospital highlighted its use of Intuitive Surgical’s da Vinci Single Port robotic platform, which enables surgeons to perform complex procedures through a single small incision. Dr. Mohammed Al-Temimi explained that the system allows […]

Peggy Johnson, a former Microsoft and Magic Leap executive who is now the CEO of Agility Robotics, used a CNBC segment to announce that her company is going public through a SPAC merger with Churchill Capital Corp., a deal she describes as the first pure-play humanoid robotics company to tap public markets. The company, a ... Humanoid Robotics CEO: The First Pure-Play Robot Company Is About to Go Public

ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the top high-conviction stocks to buy according to hedge funds. Deutsche Bank cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 on June 2 while maintaining a Sell rating on the shares. The stock also received a rating update from BofA on May 12, […]